8th Annual Tumour Models, San Francisco, CA, Jan 30-Feb 01, 2024
Conference
genOway presentation
Event
-
January 23, 2024
Jan 30-Feb 01, 2024
Implementing State-of-the-Art, Reproducible Preclinical Oncology Models to Accelerate Your Candidate’s Clinical Translatability
genOway’s presentation:
How to enhance translatability of immunotherapies in preclinical models
- Outlining BRGSF-HIS mice: Immunodeficient mice displaying functional human lymphoid and myeloid compartments, without GvHD and side effects
- Examining human cells functionality and assessing immune modulation induced by biologics in BRGSF-HIS model
- Showcase of assessment of immune targeting agents in immune checkpoint humanized models
Other news & events
Ultimate predictive models
Physiological relevance
Comprehensive and reliable validation data
Over 600 scientific articles based on our models
Scientific excellence
In-depth expertise in preclinical science, physiology, and model development
Unique R&D platform located in France
Customer-centric
Tailor-made approach to your needs
Strong emphasis on customer satisfaction
Collaborative partner
Long-standing partnerships with 17 of the top 20 pharma companies
Co-development of innovative models for next-generation drugs
Guaranteed FTO/freedom to operate